Editorial
doi: 10.1186/s13059-014-0463-6.
Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscope
- PMID: 25315013
- PMCID: PMC4318188
- DOI: 10.1186/s13059-014-0463-6
Item in Clipboard
Editorial
Tumor heterogeneity: next-generation sequencing enhances the view from the pathologist's microscope
Genome Biol.
2014.
No abstract available
Similar articles
-
Integrating next-generation sequencing into clinical cancer diagnostics.Expert Rev Mol Diagn. 2013 Sep;13(7):647-50. doi: 10.1586/14737159.2013.820551. Expert Rev Mol Diagn. 2013. PMID: 24063391 No abstract available.
-
Advancing Cancer Research and Medicine with Single-Cell Genomics.Cancer Cell. 2020 Apr 13;37(4):456-470. doi: 10.1016/j.ccell.2020.03.008. Cancer Cell. 2020. PMID: 32289270 Free PMC article. Review.
-
More Pitfalls Related to Next-generation Sequencing (NGS).Am J Clin Oncol. 2016 Aug;39(4):424. doi: 10.1097/COC.0000000000000280. Am J Clin Oncol. 2016. PMID: 27465427 No abstract available.
-
Next generation sequencing applications in cancer research.Cancer Lett. 2013 Nov 1;340(2):149-50. doi: 10.1016/j.canlet.2013.05.026. Epub 2013 Jun 11. Cancer Lett. 2013. PMID: 23764479 No abstract available.
-
Early solid tumor diagnosis through next-generation sequencing of cell-free DNA.Biomark Med. 2018 Nov;12(11):1197-1201. doi: 10.2217/bmm-2018-0269. Epub 2018 Oct 31. Biomark Med. 2018. PMID: 30379093 Review. No abstract available.
Cited by
-
Multi-staged gene expression profiling reveals potential genes and the critical pathways in kidney cancer.Sci Rep. 2022 May 4;12(1):7240. doi: 10.1038/s41598-022-11143-6. Sci Rep. 2022. PMID: 35508649 Free PMC article.
-
Insights into breast cancer phenotying through molecular omics approaches and therapy response.Cancer Drug Resist. 2019 Sep 19;2(3):527-538. doi: 10.20517/cdr.2018.009. eCollection 2019. Cancer Drug Resist. 2019. PMID: 35582587 Free PMC article. Review.
-
Profiling of Small Nucleolar RNAs by Next Generation Sequencing: Potential New Players for Breast Cancer Prognosis.PLoS One. 2016 Sep 15;11(9):e0162622. doi: 10.1371/journal.pone.0162622. eCollection 2016. PLoS One. 2016. PMID: 27631501 Free PMC article.
-
Identification of Distinct Tumor Subpopulations in Lung Adenocarcinoma via Single-Cell RNA-seq.PLoS One. 2015 Aug 25;10(8):e0135817. doi: 10.1371/journal.pone.0135817. eCollection 2015. PLoS One. 2015. PMID: 26305796 Free PMC article.
-
Current perspectives on exosomes in the diagnosis and treatment of hepatocellular carcinoma (review).Cancer Biol Ther. 2021 Apr 3;22(4):279-290. doi: 10.1080/15384047.2021.1898728. Epub 2021 Apr 13. Cancer Biol Ther. 2021. PMID: 33847207 Free PMC article. Review.
References
-
- Fisher R, Horswell S, Rowan A, Salm M, De Bruin E, Gulati S, McGranahan N, Stares M, Gerlinger M, Varela I, Crockford A, Favero F, Quidville V, Andre F, Navas C, Gronroos E, Nicol D, Hazell S, Hrouda D, O'Brien T, Matthews N, Phillimore B, Begum S, Rabinowitz A, Biggs J, Bates PA, McDonald NQ, Stamp G, Spencer-Dene B, Hsieh JJ, et al. Development of synchronous VHL syndrome tumors reveals contingencies and constraints to tumor evolution. Genome Biol. 2014;15:433. doi: 10.1186/s13059-014-0433-z. - DOI - PMC - PubMed
-
- Nadauld LD, Garcia S, Natsoulis G, Bell JM, Miotke L, Hopmans ES, Xu H, Pai RK, Palm C, Regan JF, Chen H, Flaherty P, Ootani A, Zhang NR, Ford JM, Kuo CJ, Ji HP. Metastatic tumor evolution and organoid modeling implicate TGFBR2 as a cancer driver in diffuse gastric cancer. Genome Biol. 2014;15:428. doi: 10.1186/s13059-014-0428-9. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
